Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

Published:2019-05 Issue:5 Volume:4 Page:389-398
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Li Jie,Zou Biyao,Yeo Yee Hui,Feng Yuemin,Xie Xiaoyu,Lee Dong Hyun,Fujii Hideki,Wu Yuankai,Kam Leslie Y,Ji Fanpu,Li Xiaohe,Chien Nicholas,Wei Mike,Ogawa Eiichi,Zhao Changqing,Wu Xia,Stave Christopher D,Henry Linda,Barnett Scott,Takahashi Hirokazu,Furusyo Norihiro,Eguchi Yuichiro,Hsu Yao-Chun,Lee Teng-Yu,Ren Wanhua,Qin Chengyong,Jun Dae Won,Toyoda Hidenori,Wong Vincent Wai-Sun,Cheung Ramsey,Zhu Qiang,Nguyen Mindie H

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD);Bellentani;Ann Hepatol,2009

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

3. Mechanisms of disease progression in nonalcoholic fatty liver disease;Jou;Semin Liver Dis,2008

4. Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis;Younossi;Hepatology,2018

5. NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances;Noureddin;Am J Gastroenterol,2018

Cited by 728 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zexie-Baizhu Decoction ameliorates non-alcoholic fatty liver disease through gut-adipose tissue crosstalk;Journal of Ethnopharmacology;2025-01

2. Association between non-alcoholic fatty liver disease and metabolic abnormalities in children with different weight statuses;Public Health;2024-10

3. High-density lipoprotein cholesterol trajectory and new-onset metabolic dysfunction-associated fatty liver disease incidence: a longitudinal study;Diabetology & Metabolic Syndrome;2024-09-11

4. Impact of mitochondrial lipid alterations on liver disease mechanisms and progression;Exploration of Digestive Diseases;2024-09-10

5. Nitrophenyl-group-containing Heterocycles. 3. New Isoquinolines, as antiprolifative agents against MCF7and HEGP2 Cell lines. Synthesis, characterization and biological Evaluation.;2024-09-09